Search research articles
Contact Us
Filters
Showing results (381-390 of 428) with videos related to
Page
of 43
Sort By:
Cancer Chemotherapy and Pharmacology
|
January 1, 1991
A phase I trial of continuous-infusion cyclophosphamide in refractory cancer patients
J P Eder, A D Elias, L Ayash, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
February 1, 1997
Characterization of lidocaine-specific T cells
M P Zanni, D Mauri-Hellweg, C Brander, et al.
Cancer Research
|
September 15, 1989
Evidence for enzymatic activation and oxygen involvement in cytotoxicity and antitumor activity of N,N',N''-triethylenethiophosphoramide
B A Teicher, D J Waxman, S A Holden, et al.
Seminars in Oncology
|
October 1, 1994
High-dose ifosfamide/carboplatin/etoposide with autologous hematopoietic stem cell support: safety and future directions
A D Elias, L J Ayash, C Wheeler, et al.
Cancer
|
May 15, 1993
Cisplatin, 5-fluorouracil, and etoposide for advanced non-small cell lung cancer
T J Lynch, F Kass, L A Kalish, et al.
Cancer
|
February 1, 1983
Survival of patients with localized high-grade soft tissue sarcoma with multimodality therapy. A matched control study
K H Antman, R H Blum, R E Wilson, et al.
Cancer Clinical Trials
|
January 1, 1978
A therapeutic trial of maytansine
R H Blum, B K Wittenberg, G P Canellos, et al.
Bone Marrow Transplantation
|
October 11, 2001
A short course of induction chemotherapy followed by two cycles of high-dose chemotherapy with stem cell rescue for chemotherapy naive metastatic breast cancer: sequential phase I/II studies
A D Elias, P Richardson, D Avigan, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 1, 1992
Cyclophosphamide pharmacokinetics: correlation with cardiac toxicity and tumor response
L J Ayash, J E Wright, O Tretyakov, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 1, 1983
Improved prognosis of diffuse histiocytic and undifferentiated lymphoma by use of high dose methotrexate alternating with standard agents (M-BACOD)
A T Skarin, G P Canellos, D S Rosenthal, et al.
Page
of 43
Search research articles
Search
Showing results (381-390 of 428) with videos related to
Sort By:
Page
of 43
Cancer Chemotherapy and Pharmacology
|
January 1, 1991
A phase I trial of continuous-infusion cyclophosphamide in refractory cancer patients
J P Eder, A D Elias, L Ayash, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
February 1, 1997
Characterization of lidocaine-specific T cells
M P Zanni, D Mauri-Hellweg, C Brander, et al.
Cancer Research
|
September 15, 1989
Evidence for enzymatic activation and oxygen involvement in cytotoxicity and antitumor activity of N,N',N''-triethylenethiophosphoramide
B A Teicher, D J Waxman, S A Holden, et al.
Seminars in Oncology
|
October 1, 1994
High-dose ifosfamide/carboplatin/etoposide with autologous hematopoietic stem cell support: safety and future directions
A D Elias, L J Ayash, C Wheeler, et al.
Cancer
|
May 15, 1993
Cisplatin, 5-fluorouracil, and etoposide for advanced non-small cell lung cancer
T J Lynch, F Kass, L A Kalish, et al.
Cancer
|
February 1, 1983
Survival of patients with localized high-grade soft tissue sarcoma with multimodality therapy. A matched control study
K H Antman, R H Blum, R E Wilson, et al.
Cancer Clinical Trials
|
January 1, 1978
A therapeutic trial of maytansine
R H Blum, B K Wittenberg, G P Canellos, et al.
Bone Marrow Transplantation
|
October 11, 2001
A short course of induction chemotherapy followed by two cycles of high-dose chemotherapy with stem cell rescue for chemotherapy naive metastatic breast cancer: sequential phase I/II studies
A D Elias, P Richardson, D Avigan, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 1, 1992
Cyclophosphamide pharmacokinetics: correlation with cardiac toxicity and tumor response
L J Ayash, J E Wright, O Tretyakov, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 1, 1983
Improved prognosis of diffuse histiocytic and undifferentiated lymphoma by use of high dose methotrexate alternating with standard agents (M-BACOD)
A T Skarin, G P Canellos, D S Rosenthal, et al.
Page
of 43